Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$1.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| Dec 15, 2025 |
| RLMD |
| Relmada Therapeutics, INC. |
| PBUY |
| 27,500 |
| $4.12 |
| $113.3K |
| +2.2% |
| Open the original filing on SEC.gov |
| Dec 12, 2025 | RLMD | Relmada Therapeutics, INC. | AGRANT◆ | 1.2M | — | — | — | Open the original filing on SEC.gov |
| Nov 5, 2025 | RLMD | Relmada Therapeutics, INC. | PBUY | 272,500 | $2.20 | $599.5K | +27.3% | Open the original filing on SEC.gov |
| Aug 28, 2025 | RLMD | Relmada Therapeutics, INC. | PBUY | 55,976 | $0.74 | $41.4K | +5.9% | Open the original filing on SEC.gov |
| Aug 27, 2025 | RLMD | Relmada Therapeutics, INC. | PBUY | 129,455 | $0.67 | $86.7K | +15.9% | Open the original filing on SEC.gov |
| Aug 26, 2025 | RLMD | Relmada Therapeutics, INC. | PBUY | 80,545 | $0.62 | $49.9K | +11.0% | Open the original filing on SEC.gov |
| Jun 26, 2025 | RLMD | Relmada Therapeutics, INC. | AGRANT◆ | 800,000 | — | — | — | Open the original filing on SEC.gov |
| May 20, 2025 | RLMD | Relmada Therapeutics, INC. | PBUY | 147,686 | $0.5569 | $82.2K | +25.2% | Open the original filing on SEC.gov |
| May 19, 2025 | RLMD | Relmada Therapeutics, INC. | PBUY | 30,000 | $0.4998 | $15K | +5.4% | Open the original filing on SEC.gov |
| May 16, 2025 | RLMD | Relmada Therapeutics, INC. | PBUY | 172,314 | $0.4496 | $77.5K | +44.9% | Open the original filing on SEC.gov |